Literature DB >> 31828395

Spermidine, a positive modulator of the NMDA receptor, facilitates extinction and prevents the reinstatement of morphine-induced conditioned place preference in mice.

Bruna A Girardi1, Shaiana Fabbrin1, Arithane L Wendel2, Carlos F Mello3, Maribel A Rubin4,5.   

Abstract

RATIONALE: Individuals with opioid use disorders often relapse into drug-seeking behavior after recalling memories linked to the drug use experience. Improving extinction efficacy has been used as a strategy to treat substance use disorders and suppress relapse. Although N-methyl-D-aspartate receptor (NMDAr) agonists facilitate acquisition, consolidation, and extinction, no study has addressed whether spermidine (SPD), a natural polyamine ligand of the NMDA receptor, facilitates the extinction and reinstatement of morphine-induced conditioned place preference (CPP). OBJECTIVES AND METHODS: The aim of the present study was to investigate the effect of SPD, an NMDAr agonist, on the extinction and reinstatement of morphine-induced CPP in mice. Adult male albino Swiss mice received saline (0.9% NaCl) or morphine (5 mg/kg) intraperitoneally (i.p.) and were respectively confined to a black or a white compartment for 30 min for four consecutive days for CPP induction. SPD (10-30 mg/kg, i.p.) or ifenprodil (NMDAr antagonist, 0.1-1 mg/kg, i.p.) were injected 15 min before extinction training.
RESULTS: SPD and ifenprodil facilitated the extinction of morphine-induced CPP. SPD treatment during the extinction period impaired reinstatement induced by a priming dose of morphine (1.25 mg/kg). Ifenprodil (0.1 mg/kg) prevented the facilitatory effect of spermidine on the extinction of morphine-induced CPP but did not prevent reinstatement induced by morphine.
CONCLUSIONS: These results suggest that SPD facilitated the extinction of morphine-induced CPP by modulating the polyamine binding site of the NMDA receptor. Our findings reveal important effects of SPD and ifenprodil on the re-exposure-induced decrease in morphine-induced CPP, which may be promising for developing novel pharmacological strategies to treat opioid use disorder.

Entities:  

Keywords:  Conditioned place preference; Morphine; NMDA receptor; Opioid use disorders; Reinstatement; Spermidine

Year:  2019        PMID: 31828395     DOI: 10.1007/s00213-019-05403-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  74 in total

Review 1.  Glutamate-based therapeutic approaches: NR2B receptor antagonists.

Authors:  Kathleen R Gogas
Journal:  Curr Opin Pharmacol       Date:  2005-12-22       Impact factor: 5.547

2.  Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat.

Authors:  Ghassem Attarzadeh-Yazdi; Reza Arezoomandan; Abbas Haghparast
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-04-24       Impact factor: 5.067

3.  Role of mGlu7 receptor in morphine rewarding effects is uncovered by a novel orthosteric agonist.

Authors:  Zuzana Hajasova; Corinne Canestrelli; Francine Acher; Florence Noble; Nicolas Marie
Journal:  Neuropharmacology       Date:  2018-01-04       Impact factor: 5.250

Review 4.  A brief history of opiates, opioid peptides, and opioid receptors.

Authors:  M J Brownstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

5.  Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines.

Authors:  Laetitia Mony; Shujia Zhu; Stéphanie Carvalho; Pierre Paoletti
Journal:  EMBO J       Date:  2011-06-17       Impact factor: 11.598

Review 6.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

7.  New Data on Opioid Use and Prescribing in the United States.

Authors:  Anne Schuchat; Debra Houry; Gery P Guy
Journal:  JAMA       Date:  2017-08-01       Impact factor: 56.272

8.  Stress and Rodent Models of Drug Addiction: Role of VTA-Accumbens-PFC-Amygdala Circuit.

Authors:  Jasmine J Yap; Klaus A Miczek
Journal:  Drug Discov Today Dis Models       Date:  2008

Review 9.  Glutamate and reinstatement.

Authors:  Lori A Knackstedt; Peter W Kalivas
Journal:  Curr Opin Pharmacol       Date:  2009-01-20       Impact factor: 5.547

10.  Editorial: the psychopharmacology of extinction-from theory to therapy.

Authors:  Amy L Milton; Andrew Holmes
Journal:  Psychopharmacology (Berl)       Date:  2019-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.